-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster II

Non-Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Samantha L. Kendrick, PhD1, David Tannahill, PhD2*, Shankar Balasubramanian, PhD3* and Lisa M. Rimsza, MD1

1Department of Pathology, University of Arizona, Tucson, AZ
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
3Department of Chemistry, University of Cambridge, Cambridge, United Kingdom

Leo WK Cheung1*, Karl J. Schweighofer1*, Shiquan Wu1*, Hsu-Ping Kuo1, Karl Eckert1*, Sriram Balasubramanian, PhD2, Deborah Ricci3*, Yu Liang1*, Darrin Beaupre4* and Betty Y. Chang1

1Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
2Janssen Research & Development, Springhouse, PA
3Janssen Research and Development, Raritan, NJ
4Clinical Science Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA

Keisuke Kataoka, MD, Ph.D.1*, Yasunobu Nagata, MD, Ph.D.1*, Akira Kitanaka, MD, PhD2, Jun-ichirou Yasunaga, MD, PhD3, Masako Iwanaga, M.D., Ph.D.4, Yuichi Shiraishi, MD, Ph.D.5*, Kenichi Chiba, BA5*, Aiko Sato-Otsubo, PhD1*, Masashi Sanada, MD, Ph.D.6*, Hiroko Tanaka, BA5*, Hiromichi Suzuki, MD, PhD1*, Yusuke Sato, MD, PhD1*, Yusuke Shiozawa, MD1*, Tetsuichi Yoshizato, MD1*, Kenichi Yoshida, MD, Ph.D.1*, Hideki Makishima, MD, Ph.D.1, Kisato Nosaka, MD. PhD7, Masakatsu Hishizawa8*, Hidehiro Itonaga, MD, PhD9*, Yoshitaka Imaizumi, MD, PhD10*, Wataru Munakata, MD11*, Kotaro Shide, MD, PhD2, Yoko Kubuki2*, Tomonori Hidaka2*, Takuro Kameda2*, Tsuyoshi Nakamaki, MD12, Ken Ishiyama, MD, Ph.D.13, Shuichi Miyawaki, MD14, Kensei Tobinai, MD, PhD15, Yasushi Miyazaki, MD, Ph.D.10, Akifumi Takaori-Kondo, MD, PhD8, Tatsuhiro Shibata16*, Satoru Miyano, MD, Ph.D.5*, Masao Matsuoka, MD, PhD3, Kazuya Shimoda, MD, PhD2, Toshiki Watanabe, M.D., Ph.D.17* and Seishi Ogawa, MD, Ph.D.1

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
3Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan
4Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
5Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
6Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
7Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
8Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
9Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
10Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
11Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
12Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
13Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
14Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan
15National Cancer Center Hospital, Tokyo, Japan
16Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
17Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan

Bartlomiej Getta, MBBS,1*, Omar Abdel-Wahab1, Jae H. Park, MD2 and Martin S Tallman, MD3

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Daniela Drandi1*, Elisa Genuardi1*, Paola Ghione1*, Daniele Grimaldi1*, Barbara Mantoan1*, Marina Ruggeri1*, Daniela Barbero1*, Luigia Monitillo1*, Marika Vasta1*, Eleonora Marzanati1*, Giulia Verardo1*, Paola Omedè2*, Federica Cavallo1*, Mario Boccadoro, MD1,2, Marco Ladetto3 and Simone Ferrero1*

1Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Torino, Italy
2Division of Hematology, ASO S. Giovanni Battista, Torino, Italy
3Division of Hematology, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Olga A. Gavrilina, MD1*, Eugene E. Zvonkov, MD, PhD2*, Elena N. Parovichnikova, MD, PhD2* and Valeri G. Savchenko, MD, PhD, Prof.2

1National Research Center For Hematology, Moscow, Russia
2National Research Center for Hematology, Moscow, Russia

Sandrine Roulland, Pharm.D., Ph.D.1, Nathalie Jouve1*, Agnes Bru1* and Marie-Helene Delfau-Larue, MD, PhD2,3*

1Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, INSERM U1104, Marseille, France
2EQ 9, INSERM U955, CRETEIL, France
3Department of Biological Hematology and immunology, APHP, Groupe Hospitalier Mondor, CRETEIL, France

Evgeny Arons, PhD1, Sarah Davies2*, Katherine Still2*, Nathan Chai2*, Katherine Potocka2*, Hong Zhou2* and Robert J. Kreitman, MD1

1Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Molecular Biology, National Cancer Institute/National Institute of Health, Bethesda, MD

Vaishali Aggarwal1*, Radhika Srinivasan, MD, PhD2*, Amanjit Bal, MD1*, Pankaj Malhotra, MD, MBBS3, Gaurav Prakash, MD, DM4*, Subhash Varma, MBBS, MD5* and Ashim Das, MD1*

1Department of Histopathology, PGIMER, Chandigarh, Chandigarh, India
2Department of Cytology and Gynaecological Pathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
3Department of Internal Medicine (Clinical Hematology Division), Postgraduate Institute of Medical Education & Research, Chandigarh, India
4PGIMER, Department of Internal Medicine and Hematology, Oncology, and BMT division, Chandigarh, India
5Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, India

Barbara Botto1*, Alessia Castellino1*, Annalisa Chiappella1*, Mattia Novo1*, Luigi Zattera1*, Federica Cavallo2*, Paola Ghione2*, Andrea Evangelista3*, Chiara Ciochetto1*, Giovannino Ciccone3*, Maria Stella Scalzo4*, Roberto Chiarle5, Domenico Novero4* and Umberto Vitolo1

1SC Ematologia, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
2Hematology Division, Department of Molecular Biothecnologies and Health Sciences, Torino, Italy
3Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
4Pathology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
5Department of Pathology, Boston Children's Hospital, Boston, MA

Jie He, PhD1*, Shan Zhong, PhD1*, Michelle Nahas, PhD1*, Mark Bailey1*, Jon Chung, PhD1*, Geoff Otto, PhD1*, Doron Lipson, PhD1*, Phil Stephens, PhD1*, Vincent A. Miller, MD1*, Jeff Ross, MD1,2*, Tariq I Mughal, MD1,3 and Jo-Anne Vergilio, MD1*

1Foundation Medicine, Inc., Cambridge, MA
2Albany Medical College, Albany, NY
3Tufts Medical Center, Cambridge, MA

Raji Shameem, MD1*, Muhammad Saad Hamid, MD2*, Nasheed Mohammad Hossain, MD3, Jeffrey Mufson, MD4 and Patricia L. Kropf, MD5

1Department of Hematology/Oncology, Fox Chase Cancer Center/Temple University Hospital, Philadelphia, PA
2Internal Medicine Department, Wayne State University/Detroit Medical Center, Detroit, MI
3Hematology/Medical Oncology, Fox Chase Cancer Center/Temple University Hospital, Philadelphia, PA
4Department of Medicine, Temple University Hospital, Philadelphia, PA
5Fox Chase Cancer Center, Philadelphia, PA

Gregory S. Calip, PharmD, MPH, PhD1,2,3*, Wan-Ju Lee, MS1,2*, Todd A. Lee, PharmD, PhD1,2*, Glen T. Schumock, PharmD, MBA, PhD1,2* and Brian C.-H. Chiu, PhD4

1Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL
2Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL
3Population Health, Behavior and Outcomes Program, University of Illinois Cancer Center, Chicago, IL
4Department of Public Health Sciences, The University of Chicago, Chicago, IL

Leyre Bento, MD1*, Antonia María Bautista-Gili, MD1*, Francesc García2*, Jordi Martínez-Serra, PhD1*, Lucía García-Mañó, MD1*, Marta García-Recio, MD1*, Carmen Ballester, MD1*, Jordi Ginés, MD1*, Paloma López, MD1*, Jaime Daumal1*, Rafael Ramos, MD1*, Antonio Salar, MD, PhD2*, Antonia Sampol, MD, PhD1*, Juan Besalduch, MD, PhD1 and Antonio Gutiérrez, MD, PhD1*

1Hospital Son Espases, Palma de Mallorca, Spain
2Hospital del Mar, Barcelona, Spain

Elizabeth A. Morgan, MD1, M. Patrick Sweeney2*, Tamiwe Tomoka, M.D.3*, Nadja Kopp, M.S.4*, Robert A Redd, MS5*, Christopher Daniel Carey, M.D.,6*, Leo Masamba, M.D.7*, Steve Kamiza, M.D.3*, Geraldine S Pinkus, MD8*, Donna S. Neuberg, Sc.D.9, Scott J. Rodig, M.D., Ph.D.8, Danny A. Milner Jr., M.D., M.Sc.8* and David M. Weinstock, M.D.10

1Department of Pathology, Brigham and Women's Hospital, Boston, MA
2Tulane University School of Medicine, New Orleans, LA
3Department of Histopathology, University of Malawi College of Medicine, Blantyre, Malawi
4Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
6Department of Pathology, Brigham & Women's Hospital, Boston, MA
7Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi
8Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
9Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

David Simon Kliman, MBBS1*, Louise Imlay-Gillespie, BMed1*, Kirsten McIlroy, MBBS, FRCPA2*, Anthony Gill, MBBS, MD, FRCPA2*, Christopher Arthur, MBBS, FRACP, FRCPA1, Luke Coyle, MBBS, FRACP, FRCPA1, Keith Fay, MBChB, FRACP, FRCPA1, Ian H. Kerridge, MBBS, MPhil, FRACP, FRCPA1*, Naomi Mackinlay, MBBS, FRACP, FRCPA3*, Stephen Mulligan, MBBS, PhD, FRACP, FRCPA3, William S Stevenson, MBBS, PhD, FRACP, FRCPA1, Christopher M Ward, MBChB, PhD, FRACP, FRCPA1,4 and Matthew Greenwood, MBBS, FRACP, FRCPA1*

1Department of Haematology, Royal North Shore Hospital, Sydney, Australia
2Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, Australia
3Department of Haematology, Royal North Shore Hospital, St Leonards, Australia
4Kolling Institute of Medical Research, University of Sydney, Sydney, Australia

Lobna Alkebsi, PhD1*, Hiroshi Handa, MD PhD2*, Kenichi Tahara, MD3*, Hiroaki Shimizu, PhD3*, Takuma Ishizaki, PhD3*, Kunio Yanagisawa, PhD3*, Saitoh Takayuki, MD PhD4*, Tetsuhiro Kasamatsu, PhD1*, Makiko Takizawa, MD PhD3* and Hirokazu Murakami, MD PhD1

1Graduate School of Health Sciences, Gunma University, Maebashi, Japan
2Blood Transfusion Service, Gunma University Hospital, Maebashi, Japan
3Department of Medicine and Clinical Sciences, Graduate School of Medicine, Maebashi, Japan
4Oncology Center, Gunma University Hospital, Maebashi, Japan

Branimir Spassov, MD, PhD1*, Donka Vassileva, MD, PhD2*, Georgi Michaylov, MD, PhD3*, Gueorgui Balatzenko, MD, PhD4* and Margarita Guenova, MD, PhD5*

1Department of Clinical Hematology, National Hospital for Active Therapy of Hematological Diseases, SOFIA, Bulgaria
2Laboratory of Nuclear Medicine, National Specialized Hospital for Active Treatment of Hematological Diseases, SOFIA, Bulgaria
3Department of Clinical Hematology, National Specialized Hospital for Active Treatment of Hematological Diseases, SOFIA, Bulgaria
4Laboratory of Cytogenetics & Molecular Biology, National Hospital for Active Therapy of Hematological Diseases, SOFIA, Bulgaria
5Laboratory of Hematopathology & Immunology, National Specialized Hospital for Active Treatment of Hematological Diseases, SOFIA, Bulgaria

Thai Hong Tran, PhD1*, Krupa Scott, MS1*, Shyun-Shyun Lee1*, Reshma Singh, PhD2*, Shawn Cogan2*, Jennifer Bordeaux, PhD1*, Hummel Jennifer, MD1*, Jelveh Lameh, PhD1*, Catherine Tribouley2*, Sadik Kassim3*, Shabnam Tangri, PhD1* and Naveen Dakappagari, PhD1*

1Genoptix Inc., a Novartis company, Carlsbad, CA
2Novartis Pharmaceuticals, East Hanover, NJ
3Novartis Institute of Biomedical Research, Cambridge, MA

Xuejun Tian, M.D./Ph.D.1*, Ali Shahsafaei2* and David M. Dorfman, MD, PhD3

1Pathology, Brigham and Women's Hospital / Harvard Medical School, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Department of Pathology, Brigham and Women's Hospital, Boston, MA

Zhi-Zhang Yang, M.D1, Tammy Price-troska1*, Anne J Novak, PhD2 and Stephen M Ansell, M.D., Ph.D.3

1Mayo Clinic, Rochester, MN
2College of Medicine, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN

Laurent Miguet, PhD1,2,3*, Luc Fornecker, MD4*, Marie Wyrwas5*, Sarah Cianferani6*, Raoul Herbrecht, MD4, Jean-Francois Leseve5*, Veronique Latger-Cannard5*, Caroline Mayeur-Rousse, MD1* and Laurent Mauvieux, MD, PhD1,2,3

1Hopital Hautepierre, Laboratoire d'hematologie, Strasbourg, France
2Université de Strasbourg, EA3430, Strasbourg, France
3FMTS, Strasbourg, France
4Oncology and Hematology, Hopital de Hautepierre, Strasbourg, France
5Nancy University Hospital, Nancy, France
6Laboratoire de spectrometrie de masse bioorganique (LSMBO) CNRS UMR 7178 institut pluridisciplinaire Hubert Curien Strasbourg, strasbourg, France

Matthew A Care, PhD1,2*, Stephen M Thirdborough, PhD3,4*, Andrew J Davies, MRCP PhD5*, Peter W.M. Johnson, FRCP4*, Andrew Jack, PhD, MB6, Sharon Barrans, PhD7*, David R Westhead, PhD8*, Mark S Cragg, PhD3,4*, Reuben M Tooze, PhD, FRCP1,2 and Stephen A Beers, PhD3,4*

1Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom
2Cancer Research UK Centre, Leeds, United Kingdom
3Cancer Sciences Unit, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom
4Cancer Research UK Centre, Southampton, United Kingdom
5Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom
6HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
7St James Institute of Oncology, HMDS, Leeds, United Kingdom
8Bioinformatics Group, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom

Ting Lu, MD.1*, Peng Li, MD., Ph.D1*, Chengfeng Bi, MD., Ph.D.2*, Shuang Yu, MD.1*, Daoxin Ma, MD., Ph.D1*, Kai Fu, MD, PhD2 and Chunyan Ji, MD, PhD1*

1Department of Hematology, Qilu Hospital, Shandong University, Jinan, China
2Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Zachary Hunter, PhD1*, Yang Cao, MD2*, Guang Yang, PhD1, Xia Liu, MD1*, Jie Chen, PhD1*, Lian Xu1*, Nicholas Tsakmaklis1*, Jiaji Chen1*, Christopher J Patterson, MFA1*, Jorge J Castillo, MD3 and Steven P Treon, MD, PhD1

1Bing Center for WM, Dana Farber Cancer Institute, Boston, MA
2Dept of Physiology & Biophysics, University of California, Irvine, Irvine, CA
3Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

David Foureau, Ph.D.1*, Lawrence J Druhan, PhD2, Nury M Steuerwald, PhD3*, Sarah A Baxter, PhD2*, Omotayo O. Fasan, MBBS, MRCP4*, Belinda R Avalos, MD2 and Nilanjan Ghosh, MD, PhD5

1Immnune Monitoring Core Laboratory Cannon Research Center/Carolinas Healthcare System, Charlotte, NC
2Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC
3Molecular Biology Core Facility, Carolinas HealthCare System, Charlotte, NC
41240 Lost Oak Rd, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, CHARLOTTE, NC
5Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

Greg Hapgood, MD1, Anja Mottok, MD2, Graham W Slack, MD3*, Randy D. Gascoyne3, Christian Steidl, MD2, Kerry J. Savage, MD MSc1,2 and Andrew P. Weng, MD, PhD3

1British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
2Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
3British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada

Connie Batlevi, MD, PhD1, Franck Rapaport, PhD2*, Andrew M. Intlekofer, MD, PhD1, Anne Reiner, MPH3*, Craig H Moskowitz, MD4, Steven M Horwitz, MD1, Andrew D Zelenetz, MD, PhD1, Lia Palomba, MD5, Alison J Moskowitz, MD1, John F. Gerecitano, MD6, Paul A Hamlin Jr., MD1, Amanda R. Copeland, RN, MSN, CNS1*, Matthew J Matasar, MD, MS1*, Craig S. Sauter, MD7, Anita Kumar, MD1, Ariela Noy, MD1, David J. Straus, MD1, Carol S. Portlock, MD1, Frederick Criscuolo, Phd8*, Jie He, PhD9*, Daniel Royston, MD10*, Sohail Balasubramanian, MS9*, Yekaterina Reznikovskaya, BA1*, Janine D. Pichardo, BS11*, Phil Stephens, PhD9*, Vincent Miller, MD12*, Ross L. Levine, MD6, Venkatraman Seshan, PhD13*, Ahmet Dogan, MD, PhD11 and Anas Younes, MD1

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY
9Foundation Medicine, Inc., Cambridge, MA
10Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
12Foundation Medicine, Cambridge, MA
13Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

Ruth Mary de Tute, PhD, FRCPath1*, Sharon Barrans, PhD2*, Andy C. Rawstron, PhD2, Christopher T Manbridge3*, Josh Caddy4*, Keith Pugh, PhD5*, Peter W.M. Johnson, FRCP6, Andrew J Davies, MRCP7* and Andrew Jack, PhD, MB8

1St. James's Institute of Oncology, HMDS, Leeds, United Kingdom
2St James Institute of Oncology, HMDS, Leeds, United Kingdom
3University of Southampton, Cancer Research UK Clinical Centre, Southampton, United Kingdom
4University of Southampton, SCTU, Southampton, United Kingdom
5Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
6Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom
7Southampton University, SCTU, Southampton, United Kingdom
8HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Tami Katz, Ph.D1,2*, Shoham Shivtiel-Arad, Ph.D1*, Hitam Saadi2*, Noam Bettman, PhD1*, Lina Bisharat, MSc1*, Irit Avivi, MD3* and Netanel A Horowitz, MD1,2*

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
2Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Renato Zambello1,2*, Barbara Mariotti, PhD3*, Antonella Teramo, PhD1*, Marzia Rossato, PhD3*, Gregorio Barilà, MD4*, Giulia Calabretto, BS5*, Chiara Ercolin, BS1*, Tamara Berno, MD1*, Livio Trentin, MD1, Monica Facco, MS2*, Gianpietro Semenzato6* and Flavia Bazzoni, PhD3*

1Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy
2Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
3Department of Pathology and Diagnostic, section of General Pathology, Verona University School of Medicine, Verona, Italy
4Department of Medicine Hematology and Clinical Immunology, Padova University School of Medicine, Padova, Italy
5Venetian Institute of Molecular Medicine (VIMM), Padova University School of Medicine, Padova, Italy
6Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padova, Italy

Afshin Beheshti, PhD1*, Donna S Neuberg, ScD2, J. Tyson McDonald, PhD3* and Andrew M. Evens, DO, MSc4

1Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
3Cancer Research Center, Hampton University, Hampton, VA
4Tufts Medical Center Cancer Center, Boston, MA

Tibor Bedekovics, PhD1*, Sajjad Hussain, PhD1*, Andrew L Feldman, MD2 and Paul J. Galardy, MD1

1Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN

Alexander JA Deutsch, PhD1*, Beate Rinner, PhD2*, Kerstin Wenzl, MSc1*, Katharina Troppan, MD1*, Beata Pursche1*, Hildegard T. Greinix, MD1, Christine Beham-Schmid, MD3* and Peter Neumeister, MD4*

1Internal Medicine / Hematology, Medical University Graz, Graz, Austria
2Hematology, Medical University Graz, Graz, Austria
3Institute of Pathology / Hematopathology, Medical University Graz, Graz, Austria
4Internal Medicine / Hematology, Medical Universitiy of Graz, Graz, Austria

Clémentine Sarkozy, MD1, Sarah Huet, PharmD, PhD2*, Victoria Carlton3*, Alain Delmer, MD, PhD4, Fabrice Jardin5*, Marie-Helene Delfau-Larue, MD, PhD6*, Malek Faham7* and Gilles Salles, MD, PhD8

1Hematology, Hospices Civils de Lyon, Pierre Bénite, France
2Laboratoire d’hématologie, Hospices Civils De Lyon, Pierre Bénite, France
3Adaptive Biotechnologies Corp., South San Francisco, CA
4Hematology, CHU de reims, Reims, France
5Centre Henri Becquerel, Rouen, France
6Department of Biological Hematology and immunology, APHP, Groupe Hospitalier Mondor, CRETEIL, France
7Adaptive Biotech, san francisco, CA
8Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

Lalita Norasetthada, MD1, Weerasak Nawarawong, MD2, Arnuparp Lekhakula, MD, MS3*, Jakrawadee Julamanee, MD3*, Chittima Sirijerachai, MD4*, Kanchana Chansung, MD4*, Kitsada Wudhikarn, MD5*, Udomsak Bunworasate6, Noppadol Siritanaratanakul, MD7, Archrob Khuhapinant, MD, PhD7, Tontanai Numbenjapon, MD8*, Kannadit Prayongratana, MD9*, Tawatchai Suwanban, MD10*, Suporn Chuncharunee, MD11, Pimjai Niparuck, MD11*, Somchai Wongkhantee, MD12*, Peerapon Wong, MD13*, Nisa Makruasi, MD14*, Nonglak Kanitsap, MD15* and Tanin Intragumtornchai, MD, MSc5

1Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand
2Department of Medicine, Chiang Mai University, Chiang Mai, Thailand
3Department of Internal Medicine, Prince of Songkla University, Songkla, Thailand
4Department of Medicine, Khon Kaen University, Khon Kaen, Thailand
5Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
6King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
7Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
8Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
9Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
10Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
11Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
12Department of Medicine, Khonkaen Regional Hospital, Khon Kaen, Thailand
13Department of Medicine, Naresuan University, Phitsanulok, Thailand
14Department of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand
15Department of Medicine, Thammasat University, Bangkok, Thailand

Madeleine Duvic, MD1, Steven M Horwitz, MD2, Youn H Kim, MD3, Pier Luigi Zinzani4, Gajanan Bhat, PhD5*, Pankaj Sharma6* and Sue Yancik7*

1Dept. of Dermatology, M.D. Anderson Cancer Center, Houston, TX
2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Stanford University, Palo Alto, CA
4Institute of Hematology and Oncology, University of Bologna, Bologna, Italy
5SPECTRUM PHARMACEUTICALS, INC., Irvine, CA
6spectrum pharmaceuticals, Irvine, CA
7spectrum pharmaceuticals, irvine

Xiaoyu Qu, PhD1*, Hongli Li, PhD2*, Oliver W Press, MD, PhD3, Lisa M. Rimsza, M.D.4, Rita M. Braziel, MD5, Michael Leblanc, PhD2*, Eric D. Hsi, MD6, Sonali M. Smith, MD7, Jonathan W. Friedberg, MD, MMSc8 and Min Fang, MD, PhD1*

1Fred Hutchinson Cancer Research Center, Seattle, WA
2SWOG Statistical Center, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4University of Arizona, Tucson, AZ
5Oregon Health & Science University, Portland, OR
6Cleveland Clinic, Cleveland, OH
7University of Chicago, Chicago, IL
8University of Rochester, Rochester, NY

Grzegorz Rymkiewicz, MD, PhD1*, Magdalena Chechlinska2*, Beata Grygalewicz3*, Barbara Pienkowska-Grela3*, Katarzyna Blachnio1*, Zbigniew Bystydzienski1*, Joanna Romejko-Jarosinska, MD, PhD4*, Beata Sledz-Gawronska1*, Michalina Zajdel2*, Katarzyna Domanska-Czyz5*, Renata Woroniecka3*, Kinga Sikorska-Mali1*, Jan Konrad Siwicki2*, Monika Prochorec-Sobieszek, MD, PhD6,7* and Jan Walewski, MD, PhD Prof5

1Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
2Department of Immunology, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
3Cytogenetic Laboratory, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
4Department of Lymphoid Malignancy, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
5Department of Lymphoid Malignancies, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
6Histopathology Laboratory, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
7Dept. of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Katsuhiro Miura, MD1*, Jun Konishi2*, Takaaki Miyake3*, Makita Masanori4*, Atsuko Hojo5*, Yasufumi Masaki6, Masatoshi Uno7*, Jun Ozaki8*, Chikamasa Yoshida9*, Daigo Niiya10*, Koichi Kitazume11*, Yoshinobu Maeda, MD, PhD12, Jun Takizawa, MD13*, Rika Sakai14, Yuichiro Nawa15*, Tomofumi Yano10*, Kazuhiko Yamamoto4*, Kazutaka Sunami2, Yasushi Hiramatsu16*, Kazutoshi Aoyama17*, Hideki Tsujimura18, Yoshihiro Hatta1 and Masatoshi Kanno19*

1Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
2Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
3Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan
4Department of Hematology, Okayama City Hospital, Okayama, Japan
5Division of hematology and Oncology, Kasukabe Municipal Hospital, Saitama, Japan
6Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan
7Division of Internal Medicine, Kaneda Hospital, Okayama, Japan
8Department of Hematology, Toyama Prefectural Central Hospital, Toyama, Japan
9Department of Hematology, National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan
10Department of Hematology, Okayama Rosai Hospital, Okayama, Japan
11Department of Hematology, Showa General Hospital, Tokyo, Japan
12Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
13Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
14Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
15Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Japan
16Department of Haematology and Oncology, Himeji Red Cross Hospital, Himeji, Japan
17Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan
18Department of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan
19Oncology Center, Nara Medical University Hospital, Kashihara, Japan

Michael T Zimmermann1*, Surendra Dasari1*, Rebecca L Boddicker1, Yu Zeng1*, Bruce Eckloff1*, Julie M Cunningham1*, Yanhong Wu1*, Julie C Porcher1*, Brian K Link, MD2, Stephen Ansell1, James R Cerhan, MD PhD1, Jean-Pierre Kocher1* and Andrew L Feldman, MD1

1Mayo Clinic, Rochester, MN
2Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

Cassandra Garner, BS1, Martha Glenn, MD2, Rosalie G Waller, BS3, Venkatesh Rajamanickam, MS4*, Todd Darlington, PhD5*, Rob Sargent, MS4* and Nicola J Camp, PhD2*

1Department of Human Genetics, University of Utah, Salt Lake City, UT
2Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, UT
3Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT
4Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
5Psychiatry, University of Utah, Salt Lake City

Umar Farooq, MD1, Matthew J Maurer, MS2, Stephen M Ansell, M.D., Ph.D.3, Tasha Lin, MD3, Grzegorz S. Nowakowski, MD3, Luis Porrata, MD3, David J. Inwards, MD3, William Macon, MD4*, Syrbu Sergei, MD5*, James Cerhan, MD, PhD2, Thomas E. Witzig, MD3, Brian K Link, MD1, Thomas M. Habermann, MD3 and Carrie A. Thompson, MD3

1Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
2Department of Health Sciences Research, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Department of Laboratory Medicine and Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA

Kelly A. Petrowski, MPH1*, Harsha Poola, MD2,3*, Katherine Lee Chuy, MD2*, Shweta Gupta, MD2,3 and Paul G. Rubinstein, MD1,2,3

1The Ruth M. Rothstein CORE Center, Chicago, IL
2Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
3Section of Hematology/Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

Lorenz Thurner, MD1*, Sylvia Hartmann2*, Klaus-Dieter Preuss, PhD3*, Natalie Fadle1*, Maria Kemele1*, Evi Regitz1*, Christiane Pott, MD, PhD4*, Rainer-Maria Bohle5*, Martin-Leo Hansmann2* and Michael Pfreundschuh, MD1

1José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany
2Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt Main, Frankfurt am Main, Germany
3José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany
4University Hospital Schleswig-Holstein, Kiel, Germany
5Institute of Pathology, Saarland University Medical School, Homburg/Saar, Germany

Stefano Luminari, MD, PhD1*, Maria Cecilia Goldaniga, MD2*, Marina Cesaretti1*, Sara Rattotti3*, Marco Frigeni4*, Alessandra Tedeschi5*, Paola Picardi, MD5*, Simone Ferrero, MD6*, Federica Cavallo6*, Giuseppina Cabras7*, Michele Merli, MD8*, Emanuele Cencini9*, Donato Mannina10*, Gianluca Gaidano11*, Angela Ferrari12*, Giuseppina Ricciuti13*, Rosanna Ciancia, MD14, Francesca Re, MD15*, Marcia Torresan Delamain16*, Inês B Pereira17*, Athina Lymboussaki, PhD1*, Vittoria Tarantino, MD1*, Massimo Federico, MD, PhD1 and Luca Arcaini3*

1Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
2UO Ematologia e Centro Trapianti di Midollo, IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy
3Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Unit of Hematology, Dept. of Molecular Medicine, University of Pavia & Dept. Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
5Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
6Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
7Division of Hematology, Ospedale Businco, Cagliari, Italy
8Division of Hematology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy
9Hematology Unit, Ospedale Santa Maria alle Scotte and University of Siena, Siena, Italy
10Division of Hematology, Azienda Ospedaliera Papardo, Messina, Messina, Italy
11Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
12Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
13Department of Hematology, Lymphoma Unit, Spirito Santo Hospital, Pescara, Italy
14Division of Medical Oncology, National Cancer Institute, Aviano, Italy
15Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
16Center of Hematology and Hemotherapy, Department of Internal Medicine, Faculty of Medicine, State University of Campinas, Campinas-SP, Brazil
17Portuguese Institute of Oncology, Lisbon, Portugal

Kenichi Yoshida, MD, Ph.D.1*, Rie Nakamoto-Matsubara, MD, PhD2*, Kenichi Chiba, BA3*, Yusuke Okuno, MD, Ph.D.4*, Nobuyuki Kakiuchi, MD1*, Yuichi Shiraishi, MD, Ph.D.3*, Yusuke Sato, MD, PhD1*, Hiromichi Suzuki, MD, PhD1*, Tetsuichi Yoshizato, MD1*, Yusuke Shiozawa, MD1*, Keisuke Kataoka, MD, Ph.D.1*, Hiroo Ueno, MD1*, June Takeda, MD1*, Yasunobu Nagata, MD, Ph.D.1*, Hiroko Tanaka, BA3*, Yasuo Iwadate, MD, PhD5*, Hiroaki Hondoh, MD, PhD6*, Junya Fukai, MD, PhD7*, Koji Kajiwara, MD, PhD8*, Makoto Ideguchi, MD, PhD8*, Yoshihiro Komohara, MD, PhD9*, Yukihiko Fujii, MD, PhD10*, Syunichi Kohriyama, MD, PhD11*, Masayuki Nitta, MD, PhD11*, Yoshiharu Muragaki, MD, PhD11*, Mamiko Sakata-Yanagimoto, MD, Ph.D.2*, Shingo Suzuki, PhD12*, Takashi Shiina, PhD12*, Satoru Miyano, MD, Ph.D.3*, Shigeru Chiba, MD, PhD2, Yamanaka Ryuya, MD, PhD13* and Seishi Ogawa, MD, Ph.D.1

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
3Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
6Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
7Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
8Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Yamaguchi, Japan
9Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
10Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
11Department of Neurosurgery, Faculty of Advanced Techno-Surgery(FATS), Institute of Advanced Biomedical Engineering & Science, Tokyo Women's Medical University, Tokyo, Japan
12Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Japan
13Laboratory of Molecular Target Therapy for Cancer, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

Dominic Rose, PhD*, Tamara Alpermann*, Claudia Haferlach, MD, Torsten Haferlach and Wolfgang Kern, MD

MLL Munich Leukemia Laboratory, Munich, Germany

*signifies non-member of ASH